Integrating monoclonal antibodies into the management of mantle cell lymphoma

被引：8

作者：

Berinstein, NL ^{[1
]}

Mangel, J ^{[1
]}

机构：

[1] Toronto Sunnybrook Reg Canc Ctr, Adv Therapeut Program, Toronto, ON M4N 3M5, Canada

来源：

SEMINARS IN ONCOLOGY | 2004年 / 31卷 / 01期

关键词：

D O I：

10.1053/j.seminoncol.2003.12.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2 / 6

页数：5

共 18 条

[11]

Hiddemann W, 2002, BLOOD, V100, p92A

[12]

Hiddemann W., 1996, Blood, V88, p674A

[13] The mechanisms of action of rituximab in the elimination of tumor cells [J].

Johnson, P ;

Glennie, M .

SEMINARS IN ONCOLOGY, 2003, 30 (01) :3-8

[14] Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: An active regimen for aggressive mantle-cell lymphoma [J].

Khouri, IF ;

Romaguera, J ;

Kantarjian, H ;

Palmer, JL ;

Pugh, WC ;

Korbling, M ;

Hagemeister, F ;

Samuels, B ;

Rodriguez, A ;

Giralt, S ;

Younes, A ;

Przepiorka, D ;

Claxton, D ;

Cabanillas, F ;

Champlin, R .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) :3803-3809

[15] Intensive chemotherapy and autologous stem-cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle-cell lymphoma: a matched pair analysis [J].

Mangel, J ;

Leitch, HA ;

Connors, JM ;

Buckstein, R ;

Imrie, K ;

Spaner, D ;

Crump, M ;

Pennell, N ;

Boudreau, A ;

Berinstein, NL .

ANNALS OF ONCOLOGY, 2004, 15 (02) :283-290

[16] Rituximab - A review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia [J].

Plosker, GL ;

Figgitt, DP .

DRUGS, 2003, 63 (08) :803-843

[17]

Romanello M, 2002, TELECOMMUN REP INT, V13, P8

[18] Autologous hematopoietic stem cell transplantation for mantle cell lymphoma [J].

Vose, JM ;

Bierman, PJ ;

Weisenburger, DD ;

Lynch, JC ;

Bociek, G ;

Chan, WC ;

Greiner, TC ;

Armitage, JO .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (06) :640-645

← 1 2 →